Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects

Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects

Glioblastoma multiforme (GBM) is the most common lethal primary brain malignancy without reliable therapeutic drugs. IL-13Rα2 is frequently expressed in GBMs as a molecular marker. Resveratrol (Res) effectively inhibits GBM cell growth but has not been applied in vivo because of its low brain bioava...

Full description

Bibliographic Details
Main Authors: Xiao-Min Lin, Xiao-Xiao Shi, Le Xiong, Jun-Hua Nie, Hai-Shan Ye, Jin-Zi Du, Jia Liu
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
glioblastoma
resveratrol
IL-13Rα2
Pep-PP@Res
JNK signaling
Online Access:https://www.mdpi.com/1422-0067/22/19/10622

Internet

https://www.mdpi.com/1422-0067/22/19/10622

Similar Items